Skip to main content
  • For Healthcare Professionals
  • For Patients & Caregivers

  • Important Safety Information
    • BALVERSA® (erdafitinib)
    • CONCERTA® (methylphenidate HCI)
    • DARZALEX® (daratumumab)
    • DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)
    • EDURANT® (rilpivirine)
    • ELMIRON® (pentosan polysulfate sodium)
    • ERLEADA® (apalutamide)
    • IMBRUVICA® (ibrutinib)
    • Infliximab
    • INTELENCE® (etravirine)
    • INVEGA® (paliperidone)
    • INVEGA HAFYERA™ (paliperidone palmitate)
    • INVEGA SUSTENNA® (paliperidone palmitate)
    • INVEGA TRINZA® (paliperidone palmitate)
    • INVOKAMET® (canagliflozin/metformin HCl)
    • INVOKAMET® XR (canagliflozin/metformin HCl extended-release tablets)
    • INVOKANA® (canagliflozin)
    • OPSUMIT® (macitentan)
    • PONVORY® (ponesimod)
    • PREZCOBIX® (darunavir 800 mg/ cobicistat 150 mg)
    • PREZISTA® (darunavir)
    • REMICADE® (infliximab)
    • RISPERDAL® (risperidone)
    • RISPERDAL CONSTA® (risperidone)
    • RYBREVANT® (amivantamab-vmjw)
    • SIMPONI® (golimumab)
    • SIMPONI ARIA® (golimumab)
    • SPORANOX® (itraconazole)
    • SPRAVATO® (esketamine) CIII Nasal Spray
    • STELARA® (ustekinumab)
    • SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide)
    • TECVAYLI™ (teclistamab-cqyv)
    • TOPAMAX® (topiramate)
    • TRACLEER® (bosentan)
    • TREMFYA® (guselkumab)
    • UPTRAVI® (selexipag)
    • VELETRI® (epoprostenol)
    • VENTAVIS® (iloprost)
    • XARELTO® (rivaroxaban)
    • YONDELIS® (trabectedin)
    • ZYTIGA® (abiraterone acetate)

  • Prescribing Information
    • BALVERSA® (erdafitinib) [PDF]
    • CONCERTA® (methylphenidate HCI) [PDF]
    • DARZALEX® (daratumumab) [PDF]
    • DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) [PDF]
    • EDURANT® (rilpivirine) [PDF]
    • ELMIRON® (pentosan polysulfate sodium) [PDF]
    • ERLEADA® (apalutamide) [PDF]
    • IMBRUVICA® (ibrutinib) [PDF]
    • Infliximab [PDF]
    • INTELENCE® (etravirine) [PDF]
    • INVEGA® (paliperidone) [PDF]
    • INVEGA HAFYERA™ (paliperidone palmitate) [PDF]
    • INVEGA SUSTENNA® (paliperidone palmitate) [PDF]
    • INVEGA TRINZA® (paliperidone palmitate) [PDF]
    • INVOKAMET® (canagliflozin/metformin HCl) [PDF]
    • INVOKAMET® XR (canagliflozin/metformin HCl extended-release tablets) [PDF]
    • INVOKANA® (canagliflozin) [PDF]
    • OPSUMIT® (macitentan) [PDF]
    • PONVORY® (ponesimod) [PDF]
    • PREZCOBIX® (darunavir 800 mg/ cobicistat 150 mg) [PDF]
    • PREZISTA® (darunavir) [PDF]
    • REMICADE® (infliximab) [PDF]
    • RISPERDAL® (risperidone) [PDF]
    • RISPERDAL CONSTA® (risperidone) [PDF]
    • RYBREVANT® (amivantamab-vmjw) [PDF]
    • SIMPONI® (golimumab) [PDF]
    • SIMPONI ARIA® (golimumab) [PDF]
    • SPORANOX® (itraconazole) Capsules [PDF]
    • SPORANOX® (itraconazole) Oral Solution [PDF]
    • SPRAVATO® (esketamine) CIII Nasal Spray [PDF]
    • STELARA® (ustekinumab) [PDF]
    • SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide) [PDF]
    • TECVAYLI™ (teclistamab-cqyv) [PDF]
    • TOPAMAX® (topiramate) [PDF]
    • TRACLEER® (bosentan) [PDF]
    • TREMFYA® (guselkumab) [PDF]
    • UPTRAVI® (selexipag) [PDF]
    • VELETRI® (epoprostenol) [PDF]
    • VENTAVIS® (iloprost) [PDF]
    • XARELTO® (rivaroxaban) [PDF]
    • YONDELIS® (trabectedin) [PDF]
    • ZYTIGA® (abiraterone acetate) [PDF]

Contact Us

 

Janssen Carepath

 

  • Important Safety Information
    • BALVERSA® (erdafitinib)
    • CONCERTA® (methylphenidate HCI)
    • DARZALEX® (daratumumab)
    • DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)
    • EDURANT® (rilpivirine)
    • ELMIRON® (pentosan polysulfate sodium)
    • ERLEADA® (apalutamide)
    • IMBRUVICA® (ibrutinib)
    • Infliximab
    • INTELENCE® (etravirine)
    • INVEGA® (paliperidone)
    • INVEGA HAFYERA™ (paliperidone palmitate)
    • INVEGA SUSTENNA® (paliperidone palmitate)
    • INVEGA TRINZA® (paliperidone palmitate)
    • INVOKAMET® (canagliflozin/metformin HCl)
    • INVOKAMET® XR (canagliflozin/metformin HCl extended-release tablets)
    • INVOKANA® (canagliflozin)
    • OPSUMIT® (macitentan)
    • PONVORY® (ponesimod)
    • PREZCOBIX® (darunavir 800 mg/ cobicistat 150 mg)
    • PREZISTA® (darunavir)
    • REMICADE® (infliximab)
    • RISPERDAL® (risperidone)
    • RISPERDAL CONSTA® (risperidone)
    • RYBREVANT® (amivantamab-vmjw)
    • SIMPONI® (golimumab)
    • SIMPONI ARIA® (golimumab)
    • SPORANOX® (itraconazole)
    • SPRAVATO® (esketamine) CIII Nasal Spray
    • STELARA® (ustekinumab)
    • SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide)
    • TECVAYLI™ (teclistamab-cqyv)
    • TOPAMAX® (topiramate)
    • TRACLEER® (bosentan)
    • TREMFYA® (guselkumab)
    • UPTRAVI® (selexipag)
    • VELETRI® (epoprostenol)
    • VENTAVIS® (iloprost)
    • XARELTO® (rivaroxaban)
    • YONDELIS® (trabectedin)
    • ZYTIGA® (abiraterone acetate)

  • Prescribing Information
    • BALVERSA® (erdafitinib) [PDF]
    • CONCERTA® (methylphenidate HCI) [PDF]
    • DARZALEX® (daratumumab) [PDF]
    • DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) [PDF]
    • EDURANT® (rilpivirine) [PDF]
    • ELMIRON® (pentosan polysulfate sodium) [PDF]
    • ERLEADA® (apalutamide) [PDF]
    • IMBRUVICA® (ibrutinib) [PDF]
    • Infliximab [PDF]
    • INTELENCE® (etravirine) [PDF]
    • INVEGA® (paliperidone) [PDF]
    • INVEGA HAFYERA™ (paliperidone palmitate) [PDF]
    • INVEGA SUSTENNA® (paliperidone palmitate) [PDF]
    • INVEGA TRINZA® (paliperidone palmitate) [PDF]
    • INVOKAMET® (canagliflozin/metformin HCl) [PDF]
    • INVOKAMET® XR (canagliflozin/metformin HCl extended-release tablets) [PDF]
    • INVOKANA® (canagliflozin) [PDF]
    • OPSUMIT® (macitentan) [PDF]
    • PONVORY® (ponesimod) [PDF]
    • PREZCOBIX® (darunavir 800 mg/ cobicistat 150 mg) [PDF]
    • PREZISTA® (darunavir) [PDF]
    • REMICADE® (infliximab) [PDF]
    • RISPERDAL® (risperidone) [PDF]
    • RISPERDAL CONSTA® (risperidone) [PDF]
    • RYBREVANT® (amivantamab-vmjw) [PDF]
    • SIMPONI® (golimumab) [PDF]
    • SIMPONI ARIA® (golimumab) [PDF]
    • SPORANOX® (itraconazole) Capsules [PDF]
    • SPORANOX® (itraconazole) Oral Solution [PDF]
    • SPRAVATO® (esketamine) CIII Nasal Spray [PDF]
    • STELARA® (ustekinumab) [PDF]
    • SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide) [PDF]
    • TECVAYLI™ (teclistamab-cqyv) [PDF]
    • TOPAMAX® (topiramate) [PDF]
    • TRACLEER® (bosentan) [PDF]
    • TREMFYA® (guselkumab) [PDF]
    • UPTRAVI® (selexipag) [PDF]
    • VELETRI® (epoprostenol) [PDF]
    • VENTAVIS® (iloprost) [PDF]
    • XARELTO® (rivaroxaban) [PDF]
    • YONDELIS® (trabectedin) [PDF]
    • ZYTIGA® (abiraterone acetate) [PDF]

  • For Healthcare Professionals
Feedback Icon Feedback will open a new window
Janssen Carepath

 


* required fields

You are taking the wrong survey. Kindly visit the www.janssencarepath.com/hcp site for the correct survey.

Site Map

  • Patient
  • Important Safety Information
  • Janssen Products
    • BALVERSA®
    • CONCERTA®
    • DARZALEX®
    • DARZALEX FASPRO®
    • EDURANT®
    • ELMIRON®
    • ERLEADA®
    • IMBRUVICA®
    • Infliximab
    • INTELENCE®
    • INVEGA®
    • INVEGA HAFYERA™
    • INVEGA SUSTENNA®
    • INVEGA TRINZA®
    • INVOKAMET®
    • INVOKAMET XR®
    • INVOKANA®
    • OPSUMIT®
    • PONVORY®
    • PREZCOBIX®
    • PREZISTA®
    • REMICADE®
    • RISPERDAL®
    • RISPERDAL CONSTA®
    • RYBREVANT®
    • SIMPONI®
    • SIMPONI ARIA®
    • SPORANOX®
    • STELARA®
    • SYMTUZA®
    • TECVAYLI™
    • TOPAMAX®
    • TRACLEER®
    • TREMFYA®
    • UPTRAVI®
    • VELETRI®
    • VENTAVIS®
    • XARELTO®
    • YONDELIS®
    • ZYTIGA®
  • Legal Notice
  • Privacy Policy
  • Contact Us
  • Site Map

Contact Us

Information about your insurance coverage, cost support options, and treatment support is given to you by service providers for Janssen CarePath. The information you get does not require you to use any Janssen product. Janssen CarePath cost support is not for patients in the Johnson & Johnson Patient Assistance Foundation.

This site is published by Johnson & Johnson Health Care Systems Inc. Capitalized product names are trademarks of Johnson & Johnson or its affiliated companies. This site is intended for use in the United States. Third party trademarks used herein are trademarks of their respective owners.

YONDELIS® (trabectedin) is under license from Pharma Mar, S.A.

© Johnson & Johnson Health Care Systems Inc. 2022. All rights reserved.

XARELTO® is licensed from Bayer HealthCare AG, 51368 Leverkusen, Germany.

Last updated on February 24, 2023.

Contact Us

  • Site Map

PATIENT FOOTER MENU

  • Site Map
Loading Common Footer...
 

You are leaving JanssenCarePath.com

Click “Continue” to go to the linked website. The link is for your convenience and it’s not an endorsement for the site. We encourage you to review the Privacy Policy of each site you visit.

Stay on Janssen Site
Continue